Sensus Healthcare to Present at the Raymond James Inaugural Life Sciences and MedTech Conference

BOCA RATON, Fla., June 10, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that Joe Sardano, CEO of the Company, will present a corporate overview at the Raymond James Inaugural Life Sciences and MedTech Conference on Wednesday, June […]

Sensus Healthcare to Present at the 20th Annual B. Riley FBR Investor Conference

BOCA RATON, Fla., May 15, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that Joe Sardano, CEO of the Company, will present a corporate overview at the 20th Annual B. Riley FBR Investor Conference on Thursday, May 23 […]

Sensus Healthcare Reports First Quarter 2019 Financial Results

– Premier, Inc. adds SRT to its group purchasing contracts – Ships second Sculptura™ system to Rabin Medical Center in Israel – Reaffirms expectations for double-digit full-year revenue growth – Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., May 9, 2019 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company […]

Sensus Healthcare Awarded Brachytherapy Products Agreement with Premier

BOCA RATON, Fla., May 8, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in novel radiation oncology technologies and solutions, has been awarded a group purchasing agreement for Brachytherapy Products with Premier. Effective August 1, 2019, the new agreement allows Premier members, at their discretion, to take advantage of special pricing […]

Sensus Healthcare Signs R&D Agreement to Collaborate with Perelman School of Medicine at the University of Pennsylvania on World’s First Sculptura™ Intraoperative Radiation Therapy System

Sculptura™ Provides Single Treatment During Surgery for Cancer Patients BOCA RATON, Fla., April 24, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in novel radiation oncology technologies and solutions, today announced that the Company has signed a research and development agreement with the Perelman School of Medicine at the University of […]

Five-Year Retrospective Study Shows 98.9 Percent Cure Rate for Non-Melanoma Skin Cancer Patients Treated with Sensus Healthcare’s Superficial Radio Therapy

Sensus’ SRT-100™ Indicates High Cure Rates in Long-Term Retrospective Study BOCA RATON, Fla., April 23, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in non-invasive treatments for both oncological and non-oncological conditions, announced today topline results from a five-year retrospective study of non-melanoma skin cancer (NMSC) patients treated with Superficial Radio […]

Sensus Healthcare to Present at the 31st Annual ROTH Conference

BOCA RATON, Fla., March 13, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that Joe Sardano, CEO of the Company, will present a corporate overview at the 31st Annual ROTH Conference on Tuesday, March 19 at 3:30 p.m. […]

Sensus Healthcare Launches SRT University, an Online Portal to Support Physicians

New Online Portal System to Offer Training and Education Related to SRT Devices and Technology BOCA RATON, Fla., March 12, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today the launch of SRT University, an online portal to support […]